Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.
An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...
Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...
How TikTok can be bad for your personal security, mental health, and wallet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback